Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000399421 | SCV000330287 | pathogenic | not provided | 2016-07-24 | criteria provided, single submitter | clinical testing | The W239X nonsense variant in the STK11 gene has been reported previously in association with Peutz-Jeghers syndrome (Fu et al., 2015). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Based on the currently available evidence, we consider W239X to be pathogenic. |
Invitae | RCV000796535 | SCV000936053 | pathogenic | Peutz-Jeghers syndrome | 2018-09-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp239*) in the STK11 gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in STK11 are known to be pathogenic (PMID: 15188174, 16287113). This variant has been observed in a family affected with Peutz–Jeghers syndrome (PMID: 26225618). ClinVar contains an entry for this variant (Variation ID: 280378). This variant is not present in population databases (ExAC no frequency). |
Genome- |
RCV000796535 | SCV002057375 | pathogenic | Peutz-Jeghers syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000796535 | SCV004931515 | pathogenic | Peutz-Jeghers syndrome | 2024-02-12 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. |